GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Welgene Biotech Co Ltd (ROCO:6661) » Definitions » Scaled Net Operating Assets

Welgene Biotech Co (ROCO:6661) Scaled Net Operating Assets : 0.47 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Welgene Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Welgene Biotech Co's operating assets for the quarter that ended in Mar. 2024 was NT$333.2 Mil. Welgene Biotech Co's operating liabilities for the quarter that ended in Mar. 2024 was NT$76.1 Mil. Welgene Biotech Co's Total Assets for the quarter that ended in Dec. 2023 was NT$548.2 Mil. Therefore, Welgene Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.47.


Welgene Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Welgene Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welgene Biotech Co Scaled Net Operating Assets Chart

Welgene Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.24 0.30 0.32 0.59

Welgene Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.60 0.52 0.51 0.47

Competitive Comparison of Welgene Biotech Co's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Welgene Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welgene Biotech Co's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Welgene Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Welgene Biotech Co's Scaled Net Operating Assets falls into.



Welgene Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Welgene Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(350.334-93.547)/435.713
=0.59

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=548.164 - 197.83
=350.334

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=247.894 - 118.971 - 35.376
=93.547

Welgene Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(333.225-76.126)/548.164
=0.47

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=517.441 - 184.216
=333.225

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=223.252 - 112.503 - 34.623
=76.126

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Welgene Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Welgene Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Welgene Biotech Co (ROCO:6661) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Yuanqu Street, 12th Floor, Nangang District, Taipei, TWN, 115
Welgene Biotech Co Ltd is engaged in providing clinical testing service. It service and products offerings include next-generation sequencing service, microarray service, OPS diagnostics products, and Biovesicle products. The company also offers clinical testing agents and instruments.

Welgene Biotech Co (ROCO:6661) Headlines

No Headlines